Literature DB >> 22776865

Association of bone turnover markers with mortality in men referred to coronary angiography.

E Lerchbaum1, V Schwetz, S Pilz, T B Grammer, M Look, B O Boehm, B Obermayer-Pietsch, W März.   

Abstract

UNLABELLED: We aimed to examine the association of fatal events with osteocalcin (OC) and beta-crosslaps (β-CTX) levels in men. We observed a U-shaped association of OC and β-CTX levels with fatal events in a large cohort of men at high cardiovascular risk.
INTRODUCTION: Accumulating evidence suggests an association of low OC levels with metabolic disturbances. Whether OC levels are related to fatal events is, however, less clear. Further, high β-CTX levels are linked to increased mortality. We aimed to examine the association of fatal events with both OC and β-CTX in men.
METHODS: We measured OC and β-CTX in 2,271 men referred to coronary angiography (1997-2000).
RESULTS: We observed a U-shaped association of OC and β-CTX with fatal events. Crude hazard ratios (HRs) for all-cause and non-cardiovascular mortality in the highest OC quintile were 1.38 (1.04-1.83) and 1.47 (0.89-2.40), respectively, and 2.11 (1.61-2.75) and 2.06 (1.29-3.29) for men in the lowest compared to the third OC quintile. In multivariate-adjusted models, HRs for all-cause, and non-cardiovascular mortality in the lowest OC quintile were 1.63 (1.23-2.16) and 1.79 (1.10-2.92), respectively, compared to the third OC quintile, whereas the association of high OC with mortality lost its significance. Crude and multivariate-adjusted HRs for cardiovascular mortality in the lowest OC quintile compared to the third OC quintile were 2.08 (1.49-2.90) and 1.74 (1.24-2.46), respectively. Moreover, high as well as low β-CTX levels were independently associated with all-cause (quintile 1 vs. quintile 3: HR 1.42 (1.05-1.92); quintile 5 vs. quintile 3: HR 1.79 (1.31-2.45)) and cardiovascular mortality (quintile 1 vs. quintile 3: HR 1.55 (1.05-2.28); quintile 5 vs. quintile 3: HR 1.85 (1.23-2.77)).
CONCLUSIONS: We observed a U-shaped association of OC and β-CTX with fatal events in a large cohort of men at high cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776865     DOI: 10.1007/s00198-012-2076-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  37 in total

1.  Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women.

Authors:  Tiziana Montalcini; Vittorio Emanuele; Roberto Ceravolo; Gaetano Gorgone; Giorgio Sesti; Franco Perticone; Arturo Pujia
Journal:  Am J Cardiol       Date:  2004-07-15       Impact factor: 2.778

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures.

Authors:  M T Vogt; R San Valentin; K Y Forrest; M C Nevitt; J A Cauley
Journal:  J Am Geriatr Soc       Date:  1997-02       Impact factor: 5.562

Review 4.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Authors:  B R Winkelmann; W März; B O Boehm; R Zotz; J Hager; P Hellstern; J Senges
Journal:  Pharmacogenomics       Date:  2001-02       Impact factor: 2.533

5.  Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes.

Authors:  R Reyes-Garcia; P Rozas-Moreno; J J Jimenez-Moleon; M J Lara Villoslada; J A Garcia-Salcedo; S Santana-Morales; M Muñoz-Torres
Journal:  Diabetes Metab       Date:  2011-10-12       Impact factor: 6.041

6.  Increased bone resorption in moderate smokers with low body weight: the Minos study.

Authors:  P Szulc; P Garnero; B Claustrat; F Marchand; F Duboeuf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

7.  Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification.

Authors:  Shripad N Pal; Catherine Rush; Adam Parr; Ann Van Campenhout; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2009-11-10       Impact factor: 5.162

8.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

9.  Relationship between osteocalcin and glucose metabolism in postmenopausal women.

Authors:  Jee-Aee Im; Byung-Pal Yu; Justin Y Jeon; Sang-Hwan Kim
Journal:  Clin Chim Acta       Date:  2008-07-04       Impact factor: 3.786

10.  Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.

Authors:  Ragnhild Røysland; Marc P Bonaca; Torbjørn Omland; Marc Sabatine; Sabina A Murphy; Benjamin M Scirica; Mette Bjerre; Allan Flyvbjerg; Eugene Braunwald; David A Morrow
Journal:  Heart       Date:  2012-02-28       Impact factor: 5.994

View more
  12 in total

1.  Intradialytic Calcium Kinetics and Cardiovascular Disease in Chronic Hemodialysis Patients.

Authors:  Markus Pirklbauer; Lisa Fuchs; Ramona Heiss; Thomas Ratschiller; Gert Mayer
Journal:  Blood Purif       Date:  2020-07-24       Impact factor: 2.614

Review 2.  The association between critical illness and changes in bone turnover in adults: a systematic review.

Authors:  N Orford; C Cattigan; S L Brennan; M Kotowicz; J Pasco; D J Cooper
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

Review 3.  Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.

Authors:  I Levinger; T C Brennan-Speranza; A Zulli; L Parker; X Lin; J R Lewis; B B Yeap
Journal:  Osteoporos Int       Date:  2017-03-13       Impact factor: 4.507

4.  Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Authors:  E Lerchbaum; V Schwetz; S Pilz; B O Boehm; W März
Journal:  Osteoporos Int       Date:  2013-06-18       Impact factor: 4.507

5.  Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease.

Authors:  Jing Du; Xiaoping Pan; Zhigang Lu; Meifang Gao; Xiang Hu; Xueli Zhang; Yuqian Bao; Weiping Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Relationship between Bone Health Biomarkers and Cardiovascular Risk in a General Adult Population.

Authors:  Cristina Vassalle; Laura Sabatino; Pietro Di Cecco; Maristella Maltinti; Rudina Ndreu; Silvia Maffei; Alessandro Pingitore
Journal:  Diseases       Date:  2017-10-24

7.  Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.

Authors:  Nicolas Verheyen; Astrid Fahrleitner-Pammer; Evgeny Belyavskiy; Martin R Gruebler; Hans Peter Dimai; Karin Amrein; Klemens Ablasser; Johann Martensen; Cristiana Catena; Elisabeth Pieske-Kraigher; Caterina Colantonio; Jakob Voelkl; Florian Lang; Ioana Alesutan; Andreas Meinitzer; Winfried März; Helmut Brussee; Burkert Pieske; Stefan Pilz; Andreas Tomaschitz
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

8.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

9.  Osteocalcin and carotid-femoral pulse wave velocity in patients on peritoneal dialysis.

Authors:  Po-Jui Chi; Yu-Li Lin; Jen-Pi Tasi; Chih-Hsien Wang; Jia-Sian Hou; Chung-Jen Lee; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Jan-Mar

Review 10.  Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity.

Authors:  Xuzhu Lin; Tara C Brennan-Speranza; Itamar Levinger; Bu B Yeap
Journal:  Nutrients       Date:  2018-06-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.